A safer, more sustainable target is about 1 to 2 pounds per week
Both compounds were presented once in 24 hours and examined on days 1, 2, 4, 7, and 14
14.4 MOUNJARO Use in Combination with Basal Insulin with or without Metformin in Adult Patients with Type 2 Diabetes Mellitus SURPASS-5 (NCT04039503) was a 40-week double-blind trial that randomized 475 adult patients with type 2 diabetes mellitus with inadequate glycemic control on insulin glargine 100 units/mL, with or without metformin, to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or placebo
Many patients find it easier to maintain a calorie deficit without feeling deprived
Review your drug coverage Check what coverage your insurance or provincial drug plan provides to help minimize your out-of-pocket costs The introduction of generic semaglutide in Canada has the potential to improve access to treatment by lowering medication costs for some people living with type 2 diabetes
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, studied for obesity and type 2 diabetes